To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Find out MoreBiopharma Cred. Share Price | |
---|---|
Price | 0.878 |
Bid | 0.878 |
Ask | 0.88 |
Change | 0.002 (0.23%) |
Volume | 1,651,853 |
Open | 0.874 |
High | 0.88 |
Low | 0.874 |
Prev. Close | 0.876 |
Currency | USD |
---|---|
Issue Country | GB |
Shares in Issue | 1.23b |
Market Capitalisation | $1.08b |
Market Size | 5,000 |
52 Week High | 0.966 |
52 Week High Date | 17-May-2023 |
52 Week Low | 0.81 |
52 Week Low Date | 09-Nov-2023 |
# Trades | 98 |
---|---|
Vol. Sold | 425,311 |
Sold Value | $372.65k |
Vol. Bought | 1,095,310 |
Bought Value | $961.93k |
PE Ratio | 10.60386 |
Earnings | 0.0828 |
Dividend | 0.0525 |
Yield | 5.979% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 17:10:19 | 0.87799 | 224 | Unknown* | 0.878 | 0.88 | 196.67 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:04:15 | 0.87794 | 272 | Unknown* | 0.878 | 0.88 | 238.80 | O Ordinary Was reported as OTC |
26-Apr-24 | 16:35:25 | 0.878 | 40,135 | Buy* | 0.878 | 0.88 | 35.24k | UT Uncrossing Trade |
26-Apr-24 | 16:29:37 | 0.878 | 4,935 | Sell* | 0.878 | 0.88 | 4,333 | A Automatic Execution |
26-Apr-24 | 16:29:37 | 0.878 | 2,496 | Sell* | 0.878 | 0.88 | 2,191 | A Automatic Execution |
26-Apr-24 | 16:22:10 | 0.878 | 4,672 | Sell* | 0.878 | 0.88 | 4,102 | A Automatic Execution |
26-Apr-24 | 16:22:10 | 0.878 | 5,807 | Sell* | 0.878 | 0.88 | 5,099 | A Automatic Execution |
26-Apr-24 | 16:21:10 | 0.881189 | 3,100 | Unknown* | 0.878 | 0.88 | 2,732 | O Ordinary Non protected portfolio Single protected transaction |
26-Apr-24 | 16:20:22 | 0.878 | 2,196 | Sell* | 0.878 | 0.88 | 1,928 | A Automatic Execution |
26-Apr-24 | 16:18:10 | 0.87698 | 5,800 | Sell* | 0.876 | 0.88 | 5,086 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
27-Mar-24 | 27-Mar-24 | Buy | Sapna Shah held the position of Non-Executive Director at the time of this trade.Sapna Shah | 71.51 | GBX | 20,000 | 75,275 |
25-Mar-24 | 15-Mar-24 | Buy Dividends | Harry Abraham Hyman held the position of Chairman at the time of this trade.Harry Abraham Hyman | 69.21 | GBX | 109 | 208,900 |
22-Jan-24 | 05-Jan-24 | Buy Dividends | Harry Abraham Hyman held the position of Chairman at the time of this trade.Harry Abraham Hyman | 72.47 | GBX | 126 | 208,791 |
16-May-23 | 05-May-23 | Buy Dividends | Harry Abraham Hyman held the position of Chairman at the time of this trade.Harry Abraham Hyman | 73.51 | GBX | 103 | 208,665 |
29-Mar-23 | 27-Mar-23 | Buy | Sapna Shah held the position of Non-Executive Director at the time of this trade.Sapna Shah | 97.00 | GBX | 15,075 | 55,275 |